Strategies for hepatocellular carcinoma therapy and diagnostics: lessons learned from high throughput and profiling approaches. (Q37857056)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21433041%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

review article

1 reference

title

Strategies for hepatocellular carcinoma therapy and diagnostics: lessons learned from high throughput and profiling approaches (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21433041%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

main subject

hepatocellular carcinoma

1 reference

1 reference

Peter Schirmacher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21433041%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

language of work or name

English

0 references

publication date

1 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21433041%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21433041%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21433041%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21433041%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

2112-2121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21433041%20AND%20SRC:MED&resulttype=core&format=json

Management of hepatocellular carcinoma: An update

26 January 2020

cites work

1 reference

Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia

21 January 2018

1 reference

Experimental models of hepatocellular carcinoma

21 January 2018

1 reference

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma

21 January 2018

1 reference

Oncolytic virotherapy for advanced liver tumours.

21 January 2018

1 reference

Etiology-dependent molecular mechanisms in human hepatocarcinogenesis

21 January 2018

1 reference

Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection.

21 January 2018

1 reference

Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma

21 January 2018

1 reference

A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells

21 January 2018

1 reference

Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade--results of an explorative CGH meta-analysis

21 January 2018

1 reference

Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma

21 January 2018

1 reference

International network of cancer genome projects

21 January 2018

1 reference

A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data.

21 January 2018

1 reference

Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q.

21 January 2018

1 reference

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach

21 January 2018

1 reference

Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.

21 January 2018

1 reference

p53 mutation heterogeneity in cancer

21 January 2018

1 reference

Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas

21 January 2018

1 reference

Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.

21 January 2018

1 reference

M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity

21 January 2018

1 reference

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

21 January 2018

1 reference

Frequent k- ras -2 mutations and p16(INK4A)methylation in hepatocellular carcinomas in workers exposed to vinyl chloride

21 January 2018

1 reference

Induction of Tumors in Mice by Genomic Hypomethylation

21 January 2018

1 reference

Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.

21 January 2018

1 reference

Aberrant CpG Island Hypermethylation Along Multistep Hepatocarcinogenesis

21 January 2018

1 reference

Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors

21 January 2018

1 reference

Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma

21 January 2018

1 reference

Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma.

21 January 2018

1 reference

Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.

21 January 2018

1 reference

Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges

21 January 2018

1 reference

Gene expression patterns in human liver cancers

21 January 2018

1 reference

Focal gains of VEGFA and molecular classification of hepatocellular carcinoma

21 January 2018

1 reference

Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling.

21 January 2018

1 reference

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

21 January 2018

1 reference

Most mammalian mRNAs are conserved targets of microRNAs

21 January 2018

1 reference

MicroRNA-373 induces expression of genes with complementary promoter sequences

21 January 2018

1 reference

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

21 January 2018

1 reference

miR-221 overexpression contributes to liver tumorigenesis

21 January 2018

1 reference

MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.

21 January 2018

1 reference

Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma

21 January 2018

1 reference

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations

21 January 2018

1 reference

Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues

21 January 2018

1 reference

Identification of metastasis-related microRNAs in hepatocellular carcinoma

21 January 2018

1 reference

Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

21 January 2018

1 reference

MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma

21 January 2018

1 reference

Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma

21 January 2018

1 reference

MicroRNA expression, survival, and response to interferon in liver cancer

21 January 2018

1 reference

The MicroRNA miR-139 Suppresses Metastasis and Progression of Hepatocellular Carcinoma by Down-regulating Rho-Kinase 2

21 January 2018

1 reference

MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2.

21 January 2018

1 reference

Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells

21 January 2018

1 reference

Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer

21 January 2018

1 reference

Integrating gene and protein expression data: pattern analysis and profile mining

21 January 2018

1 reference

Investigating the correspondence between transcriptomic and proteomic expression profiles using coupled cluster models

21 January 2018

1 reference

Differential proteomics identification of HSP90 as potential serum biomarker in hepatocellular carcinoma by two-dimensional electrophoresis and mass spectrometry

21 January 2018

1 reference

Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markers.

21 January 2018

1 reference

Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma

21 January 2018

1 reference

Epigenetic methylation and expression of caspase 8 and survivin in hepatocellular carcinoma.

21 January 2018

1 reference

Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells

21 January 2018

1 reference

Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma

21 January 2018

1 reference

Signaling Networks in Human Hepatocarcinogenesis—Novel Aspects and Therapeutic Options

21 January 2018

1 reference

Dysregulation of growth factor signaling in human hepatocellular carcinoma.

21 January 2018

1 reference

Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis

21 January 2018

1 reference

Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets.

21 January 2018

1 reference

Identification of potential driver genes in human liver carcinoma by genomewide screening

21 January 2018

1 reference

Hepatitis B virus-associated multistep hepatocarcinogenesis: a stepwise increase in allelic alterations

21 January 2018

1 reference

Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa

21 January 2018

1 reference

AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1

21 January 2018

1 reference

The genomic landscapes of human breast and colorectal cancers

21 January 2018

1 reference

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

21 January 2018

1 reference

Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma

21 January 2018

1 reference

Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis

21 January 2018

1 reference

Pivotal role of mTOR signaling in hepatocellular carcinoma

21 January 2018

1 reference

Design and endpoints of clinical trials in hepatocellular carcinoma.

21 January 2018

1 reference

I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy

21 January 2018

1 reference

Optimizing trial design: sequential, adaptive, and enrichment strategies

21 January 2018

1 reference

Targeting heat shock protein 90 with non-quinone inhibitors: a novel chemotherapeutic approach in human hepatocellular carcinoma.

21 January 2018

1 reference

Drug resistance associated with antiangiogenesis therapy

21 January 2018

1 reference

The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex

21 January 2018

1 reference

TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs

21 January 2018

1 reference

Identification of aneuploidy-tolerating mutations

21 January 2018

1 reference

Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.

21 January 2018

1 reference

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer

21 January 2018

1 reference

Sorafenib: where do we go from here?

21 January 2018

1 reference

Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis

21 January 2018

1 reference

PTEN/MMAC1 mutations in hepatocellular carcinomas

21 January 2018

1 reference

Molecular-based prediction of early recurrence in hepatocellular carcinoma

21 January 2018

1 reference

7 January 2021

High frequency of p16INK4A gene alterations in hepatocellular carcinoma

1 reference

7 January 2021

Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression

1 reference

7 January 2021

Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinoma

1 reference

7 January 2021

Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinomas--an enhanced immunohistochemical approach

1 reference

7 January 2021

Factors of transforming growth factor beta signalling are co-regulated in human hepatocellular carcinoma

1 reference

7 January 2021

Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression

1 reference

7 January 2021

Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease

1 reference

7 January 2021

The platinum-based treatments for advanced non-small cell lung cancer, is low/negative ERCC1 expression better than high/positive ERCC1 expression? A meta-analysis

1 reference

7 January 2021

Low incidence of p53 mutations in European hepatocellular carcinomas with heterogeneous mutation as a rare event

1 reference

7 January 2021

Molecular pathogenesis of hepatocellular carcinoma

1 reference

7 January 2021

M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan

1 reference

7 January 2021

Smad2 and Smad4 gene mutations in hepatocellular carcinoma

1 reference

7 January 2021

Epigenetic and genetic alterations of PTEN in hepatocellular carcinoma

1 reference

7 January 2021

Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in hepatocellular carcinoma

1 reference

7 January 2021